Hetero Labs Recalls Valacyclovir Tablets Due to Temperature Exposure
Hetero Labs Limited is recalling Valacyclovir Tablets USP 1 gram because they were exposed to higher temperatures during transport. The recall covers 48,132 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The hazard is temperature exposure, which is a quality control issue rather than a direct contamination or structural defect, and no illnesses or injuries are reported in the source text.
Plain-English summary
Hetero Labs Limited Unit V is recalling Valacyclovir Tablets USP 1 gram, 30-count bottles, manufactured for Camber Pharmaceuticals, Inc. The recall involves 48,132 bottles of the prescription medication, identified by Lot # VLC17027 with an expiration date of 07-2019. The product was distributed in New Jersey and then nationwide in the United States.
The recall was initiated because the Valacyclovir Tablets, along with Valganciclovir Tablets USP 450 mg and Famciclovir complaint batches, were exposed to higher temperatures at an airport or in cargo. This temperature abuse occurred within the same consignment as the previously recalled Famciclovir batch (D-0415-2018).
Consumers and healthcare providers should check their inventory for Valacyclovir Tablets USP 1 gram with Lot # VLC17027 and NDC # 31722-705-30. If found, these products should be discontinued and returned to the supplier or disposed of according to local regulations. Patients should consult their healthcare provider for alternative treatment options if they have been prescribed this specific lot.
The recalled product
- Product
- VALACYCLOVIR (VALACYCLOVIR)
- Brand
- VALACYCLOVIR
- Manufacturer
- Hetero Labs Limited Unit V
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # VLC17027 Exp 07-2019
UPCs (2)
- 0331722704304
- 0331722705301
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Hetero Labs Limited Unit V under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Hetero Labs Limited Unit V
See all →- ModeratePantoprazole Sodium Tablets Recalled for Discoloration Issues
FDA (Drugs) · 2026-04-29
- ModerateHetero Labs Recalls Losartan Potassium Tablets Due to Bulging Complaints
FDA (Drugs) · 2020-09-02
- ModerateHetero Recalls Montelukast Sodium Tablets Due to Blue Specks
FDA (Drugs) · 2018-10-03
- CriticalHetero Labs Recalls Montelukast Sodium Tablets Due to Labeling Error
FDA (Drugs) · 2018-10-03
- SevereHetero Labs Recalls Valsartan Tablets Due to Carcinogen Impurity
FDA (Drugs) · 2018-08-29
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18